NADAC acquisition cost data for PROBENECID-COLCHICINE TABLET. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 00591532501 | $0.9941 | 2022-12-21 | Rx |
| 50742026301 | $0.9941 | 2022-12-21 | Rx |
| 00591532501 | $0.9941 | 2022-12-21 | Rx |
| 50742026301 | $0.9941 | 2022-12-21 | Rx |
Generic: Probenecid/Colchicine | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $963.8K | 18,589 | 14,698 | $0.7070 |
| 2020 | $2.8M | 39,640 | 13,297 | $0.8866 |
| 2021 | $3.1M | 37,888 | 11,813 | $1.03 |
| 2022 | $2.6M | 32,774 | 10,044 | $1.04 |
| 2023 | $2.2M | 29,545 | 8,789 | $0.9561 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| California | $158.0K | 1,917 | 620 |
| Texas | $133.4K | 1,770 | 576 |
| Florida | $120.0K | 1,508 | 516 |
| Georgia | $115.3K | 1,773 | 446 |
| North Carolina | $113.0K | 1,449 | 427 |
| Ohio | $96.3K | 1,320 | 385 |
| Michigan | $86.6K | 1,094 | 324 |
| Virginia | $82.7K | 977 | 298 |
| Mississippi | $82.3K | 1,218 | 342 |
| New York | $73.8K | 988 | 298 |
| Tennessee | $68.8K | 959 | 334 |
| Alabama | $67.3K | 929 | 277 |
| Wisconsin | $65.5K | 861 | 276 |
| Pennsylvania | $64.5K | 924 | 233 |
| Illinois | $64.3K | 1,041 | 333 |
| Missouri | $60.1K | 805 | 210 |
| South Carolina | $51.6K | 661 | 219 |
| Indiana | $47.1K | 606 | 182 |
| Louisiana | $46.1K | 682 | 205 |
| Kentucky | $45.4K | 645 | 180 |
| Massachusetts | $43.2K | 595 | 175 |
| Maryland | $42.6K | 483 | 156 |
| Washington | $40.4K | 489 | 156 |
| Arkansas | $38.7K | 531 | 133 |
| Hawaii | $35.1K | 462 | 162 |
| Iowa | $33.1K | 450 | 132 |
| New Jersey | $30.0K | 343 | 105 |
| Oregon | $29.0K | 377 | 116 |
| Minnesota | $26.4K | 337 | 103 |
| Nebraska | $25.8K | 371 | 96 |
| Arizona | $22.4K | 203 | 68 |
| West Virginia | $21.4K | 247 | 69 |
| Utah | $20.2K | 264 | 101 |
| Kansas | $19.0K | 278 | 74 |
| Rhode Island | $18.4K | 203 | 45 |
| Oklahoma | $16.4K | 242 | 100 |
| Colorado | $15.8K | 190 | 73 |
| Nevada | $15.7K | 163 | 58 |
| Wyoming | $12.2K | 145 | 47 |
| New Mexico | $11.2K | 137 | 46 |
| Connecticut | $11.2K | 145 | 44 |
| Idaho | $10.5K | 159 | 48 |
| Montana | $9.9K | 168 | 28 |
| Maine | $6.2K | 95 | 21 |
| New Hampshire | $5.9K | 80 | 20 |
| South Dakota | $4.6K | 75 | 23 |
| Delaware | $4.3K | 51 | 16 |
| Puerto Rico | $3.5K | 56 | 19 |
| Vermont | $2.4K | 21 | N/A |
| Alaska | $1.4K | 19 | N/A |
| North Dakota | $991.40 | 20 | N/A |
| District of Columbia | $960.42 | 11 | N/A |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.